Gabapentin
Product Images NDC 50090-2794

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-2794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
This text appears to be a table showing a medication study with two different periods: a 3-week dose titration period and a 4-week fixed dose period. The table includes information about the placebo group and a group that received Gabapentin in doses of either 1800 mg/day or 2400 mg/day. There are also mean pain scores for each group at various weeks.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
The given text displays a chart with different percentages listed on the Y-axis and a list of studies on the X-axis. The chart represents the proportion of responders with more than 50% reduction in pain score in controlled PHN Studies. The chart shows Study 1 and Study 2, with different percentages for each category listed under the studies. The chart has a note on the top stating "#p<001 and O b<0,001".*
FDA Label Image

Figure4 (Figure4)

FDA Label Image

Label Image (Lbl500902794)

FDA Label Image

Scale (Scale)

Scale (Scale)
This text likely represents medical data, specifically information related to calculating the estimated creatinine clearance (CLCr) for a patient. The age and serum creatinine level are key factors in this calculation, although there seems to be some missing or unclear information. A correction factor of 0.85 appears to be relevant for female patients, but the exact value of CLCr cannot be determined without additional information.*
FDA Label Image

Structuralformula (Structuralformula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.